Avidity Biosciences Inc
NASDAQ:RNA

Watchlist Manager
Avidity Biosciences Inc Logo
Avidity Biosciences Inc
NASDAQ:RNA
Watchlist
Price: 71.86 USD 0.04% Market Closed
Market Cap: 10.8B USD

P/E
Price to Earnings

-19.2
Current
-9.8
Median
23.7
Industry
Lower than median
Lower than industry value

The Price to Earnings (P/E) ratio shows how much investors are willing to pay for each dollar of a company’s earnings. It’s calculated by dividing the company’s market value by its net income.

P/E
-19.2
=
Market Cap
10.5B USD
/
Net Income
-549.8m USD
All Countries
Close
Earnings Growth PEG
US
Avidity Biosciences Inc
NASDAQ:RNA
Average P/E: 187.6
Negative Multiple: -19.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 354 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171.2
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
9%
1.9
AU
CSL Ltd
ASX:CSL
19.1
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 184.3
N/A N/A
NL
argenx SE
XBRU:ARGX
33.9
40%
0.8

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-15.2
2-Years Forward
P/E
-13.1
3-Years Forward
P/E
-16.3